NO855169L - Oljeadjuvert vaksine, og fremgangsmaate til dens fremstilling. - Google Patents

Oljeadjuvert vaksine, og fremgangsmaate til dens fremstilling.

Info

Publication number
NO855169L
NO855169L NO855169A NO855169A NO855169L NO 855169 L NO855169 L NO 855169L NO 855169 A NO855169 A NO 855169A NO 855169 A NO855169 A NO 855169A NO 855169 L NO855169 L NO 855169L
Authority
NO
Norway
Prior art keywords
vaccine
optionally
adjuvant
oil
formula
Prior art date
Application number
NO855169A
Other languages
English (en)
Norwegian (no)
Inventor
Dieter Bernhardt
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of NO855169L publication Critical patent/NO855169L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO855169A 1984-12-20 1985-12-19 Oljeadjuvert vaksine, og fremgangsmaate til dens fremstilling. NO855169L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843446515 DE3446515A1 (de) 1984-12-20 1984-12-20 Oeladjuvierte vaccine und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
NO855169L true NO855169L (no) 1986-06-23

Family

ID=6253325

Family Applications (1)

Application Number Title Priority Date Filing Date
NO855169A NO855169L (no) 1984-12-20 1985-12-19 Oljeadjuvert vaksine, og fremgangsmaate til dens fremstilling.

Country Status (8)

Country Link
EP (1) EP0187286A1 (en])
DE (1) DE3446515A1 (en])
DK (1) DK593985A (en])
ES (1) ES8801583A1 (en])
FI (1) FI855057A7 (en])
GR (1) GR853058B (en])
NO (1) NO855169L (en])
PT (1) PT81713B (en])

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4806350A (en) * 1986-04-18 1989-02-21 Norden Laboratories, Inc. Vaccine formulation
DE3817531A1 (de) * 1988-05-24 1989-12-07 Behringwerke Ag Antigenloesung enthaltend ein polyalphaolefin (pao), verfahren ihrer herstellung und die verwendung von pao als adjuvans
DK17093D0 (da) * 1993-02-15 1993-02-15 Lyfjathroun H F Farmaceutisk praeparat til topisk administrering af antigener og/eller vacciner til pattedyr via slimhinder
US5718904A (en) * 1995-06-02 1998-02-17 American Home Products Corporation Adjuvants for viral vaccines
JP5220248B2 (ja) * 1997-08-29 2013-06-26 アンチジェニックス・インコーポレイテッド アジュバントｑｓ−２１および賦形剤としてポリソルベートまたはシクロデキストリンを含む組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL269002A (en]) * 1960-09-06
GB1083815A (en) * 1963-10-01 1967-09-20 Wellcome Found Vaccine adjuvants
GB1035701A (en) * 1964-03-03 1966-07-13 Merck & Co Inc Emulsions suitable for use as adjuvants for immunological agents
GB1128325A (en) * 1964-11-11 1968-09-25 Wellcome Found Improvements in water-in-oil emulsion vaccines
GB1081796A (en) * 1965-08-13 1967-08-31 Wright Fleming Inst Of Microbi Improvements in or relating to oily adjuvants for water-in-oil emulsions of antigenic materials
DE3261734D1 (en) * 1981-03-03 1985-02-14 Centraal Diergeneeskundig Inst Water-in-oil emulsion for use in the potentation of the immune system of animals
DE3308458A1 (de) * 1983-03-10 1984-09-13 Behringwerke Ag, 3550 Marburg Verfahren zur adjuvierung von vaccinen

Also Published As

Publication number Publication date
ES8801583A1 (es) 1988-02-16
FI855057L (fi) 1986-06-21
ES550089A0 (es) 1988-02-16
GR853058B (en]) 1986-04-15
DK593985A (da) 1986-06-21
FI855057A7 (fi) 1986-06-21
PT81713A (de) 1986-01-01
DE3446515A1 (de) 1986-06-26
DK593985D0 (da) 1985-12-19
PT81713B (de) 1987-08-10
EP0187286A1 (de) 1986-07-16
FI855057A0 (fi) 1985-12-18

Similar Documents

Publication Publication Date Title
AU2021201721B2 (en) Neisseria meningitidis compositions and methods thereof
RU2432173C2 (ru) Вакцины, содержащие алюминиевые адъюванты и гистидин
RU2323002C2 (ru) Вакцины, содержащие алюминиевые адъюванты и гистидин
Claassen et al. Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine
JP5074644B2 (ja) 組合わせの髄膜炎菌ｂ／ｃワクチン
AU706053B2 (en) Modified meningococcal polysaccharide conjugate vaccines
AU2002330681A1 (en) Vaccines comprising aluminium adjuvants and histidine
CN107961367B (zh) 使免疫原性组合物中的LP2086(fHBP)亚族B多肽的效力稳定化的方法
Cryz Jr et al. Safety and immunogenicity of a polyvalentKlebsiella capsular polysaccharide vaccine in humans
IE48402B1 (en) Pasteurellosis vaccines
JP2003514868A (ja) 血清型ＢおよびＣ由来のＮｅｉｓｓｅｒｉａｍｅｎｉｎｇｉｔｉｄｉｓ抗原、ならびにさらなる抗原を含む組成物
Nagaputra et al. Neisseria meningitidis native outer membrane vesicles containing different lipopolysaccharide glycoforms as adjuvants for meningococcal and nonmeningococcal antigens
US20180271969A1 (en) Streptococcus suis polysaccharide-protein conjugate composition
US5616328A (en) Method of preparing gram-negative bacterial vaccines
RU2127121C1 (ru) Способ получения вакцинной композиции против кишечной инфекции
Hatano et al. Immunogenic and antigenic properties of a heptavalent high-molecular-weight O-polysaccharide vaccine derived from Pseudomonas aeruginosa
NO855169L (no) Oljeadjuvert vaksine, og fremgangsmaate til dens fremstilling.
Paoletti et al. Immunogenicity of group B Streptococcus type III polysaccharide-tetanus toxoid vaccine in baboons
CN107670028B (zh) 一种鸭疫里默氏菌灭活菌苗和抗体的复合油乳剂疫苗及其制备方法
Kumar et al. Immune response and viscosity of haemorrhagic septicaemia oil adjuvant vaccine at different water-oil proportion
CN110507819B (zh) 青蒿琥酯作为免疫佐剂在制备狂犬病疫苗中的应用
Cryz Jr et al. A polyvalent Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine
JP6689993B2 (ja) アミロイドコンジュゲート並びにその使用及び方法
AU2004216554B2 (en) Subcutaneously-administered ganglioside-based vaccine compositions
RU2026342C1 (ru) Штамм коксиелл coxiella burnetii, используемый для получения инактивированной вакцины против ку-лихорадки